Jelbart M E, Russell P J, Fullerton M, Russell P, Funder J, Raghavan D
Department of Surgery, University of Sydney, Australia.
Mol Cell Endocrinol. 1988 Feb;55(2-3):167-72. doi: 10.1016/0303-7207(88)90131-1.
The xenograft line, UCRU-PR-2, has been characterized further. Established from a primary human undifferentiated small cell carcinoma of the prostate, it has been maintained as a stable xenograft line in nude mice and is currently in passage 9. The tumor has maintained the features of small cell undifferentiated carcinoma but shows epithelial as well as neuroendocrine characteristics. In this paper, we describe synthesis and secretion of peptide hormones, ACTH, beta-endorphin and somatostatin in vivo and ACTH and beta-endorphin in vitro by the tumor, UCRU-PR-2. This suggests that the gene for proopiomelanocortin is expressed and that processing of the molecule occurs. This line may yield insights into the histogenesis of the subtypes of prostate cancer, and also aid studies of regulation of ectopic hormone production.
异种移植系UCRU-PR-2已得到进一步鉴定。它源自原发性人前列腺未分化小细胞癌,在裸鼠中作为稳定的异种移植系得以维持,目前传至第9代。该肿瘤保留了未分化小细胞癌的特征,但同时显示出上皮及神经内分泌特征。在本文中,我们描述了肿瘤UCRU-PR-2在体内合成和分泌肽类激素促肾上腺皮质激素(ACTH)、β-内啡肽和生长抑素,以及在体外合成和分泌ACTH和β-内啡肽的情况。这表明阿黑皮素原基因得以表达且该分子发生了加工处理。该细胞系可能有助于深入了解前列腺癌亚型的组织发生,也有助于异位激素产生调控的研究。